Publikationsdatum:
2018-02-13
Beschreibung:
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells, Published online: 12 February 2018; doi:10.1038/nm.4484 Combining the kinase inhibitor sorafenib with allogeneic stem cell transplantation boosts immune responses against a subtype of acute myelogenous leukemia, suggesting potential clinical benefit.
Print ISSN:
1078-8956
Digitale ISSN:
1546-170X
Thema:
Biologie
,
Medizin
Permalink